Harvard Study Presents an Injectable Vaccine Causing Immunity Against Acute Myeloid Leukemia (AML) in Mice

According to a recent article in the Harvard Gazette, researchers from Harvard announced the results of a study involving animal models that brought about immunity and lasting recovery against acute…

Continue Reading Harvard Study Presents an Injectable Vaccine Causing Immunity Against Acute Myeloid Leukemia (AML) in Mice
Questions for COVID-19: Should Cancer Patients Attend Appointments?
Photo by National Cancer Institute on Unsplash

Questions for COVID-19: Should Cancer Patients Attend Appointments?

  In a period of unprecedented changes, it is understandable that people may question what their lives may look like moving forward. COVID-19 has now spread to 196 countries and…

Continue Reading Questions for COVID-19: Should Cancer Patients Attend Appointments?
Coronavirus/COVID-19: What Cancer Patients, Caregivers, and Survivors Need to Know
source: pixabay.com

Coronavirus/COVID-19: What Cancer Patients, Caregivers, and Survivors Need to Know

According to a story from LocalHealthGuide, COVID-19 has continued to spread through the US and the lackluster government response suggests that it isn't going to be contained any time soon.…

Continue Reading Coronavirus/COVID-19: What Cancer Patients, Caregivers, and Survivors Need to Know
ICYMI: An Observational Blood Cancer Study is Starting to Recruit Patients
source: pixabay.com

ICYMI: An Observational Blood Cancer Study is Starting to Recruit Patients

According to a story from Financial Buzz, the precision oncology company Notable has recently announced that it has opened enrollment for a new observational clinical trial that will focus on…

Continue Reading ICYMI: An Observational Blood Cancer Study is Starting to Recruit Patients
ICYMI: A New Phase 3 Trial for Acute Myeloid Leukemia is Now Enrolling Patients
source: pixabay.com

ICYMI: A New Phase 3 Trial for Acute Myeloid Leukemia is Now Enrolling Patients

SELLAS has just announced that patient screening has begun for a Phase 3 trial for acute myeloid leukemia (AML). The trial is examining the effects of GPS for patients who…

Continue Reading ICYMI: A New Phase 3 Trial for Acute Myeloid Leukemia is Now Enrolling Patients

Pediatric Cancer and the 70th Anniversary of the Leukemia & Lymphoma Society

  When the Leukemia & Lymphoma Society (LLS) was founded in 1949 by a family in memory of their sixteen-year-old son, cancer was considered a hopeless condition. As noted recently…

Continue Reading Pediatric Cancer and the 70th Anniversary of the Leukemia & Lymphoma Society

FDA Approves an Experimental Treatment of Various Blood Malignancies for Clinical Trials

According to a story from First World Pharma, the biopharmaceutical company Mustang Bio, Inc. recently announced that the US Food and Drug Administration (FDA) has approved their investigational new drug…

Continue Reading FDA Approves an Experimental Treatment of Various Blood Malignancies for Clinical Trials

Experimental Treatment for Acute Myeloid Leukemia Earns Orphan Drug Designation

According to a story from globenewswire.com, the biopharmaceutical company Mustang Bio, Inc. has recently announced that the US Food and Drug Administration (FDA) has recently awarded the company Orphan Drug…

Continue Reading Experimental Treatment for Acute Myeloid Leukemia Earns Orphan Drug Designation
China Approves Early Acute Myeloid Leukemia Clinical Trial
JLB1988 / Pixabay

China Approves Early Acute Myeloid Leukemia Clinical Trial

According to a story from BioPortfolio, the biopharmaceutical company CStone Pharmaceuticals has recently announced that China's National Medical Product Administration (NMPA) has issued approval for the company to conduct a…

Continue Reading China Approves Early Acute Myeloid Leukemia Clinical Trial

The New 5F9 Antibody Looks Encouraging as it Targets MDS and AML Leukemia in a Phase 1b Clinical Trial

  The California Institute for Regenerative Medicine (CIRM) has funded a study by a company called Forty Seven, Inc. The clinical trial is investigating the benefits of a drug therapy for two cancers…

Continue Reading The New 5F9 Antibody Looks Encouraging as it Targets MDS and AML Leukemia in a Phase 1b Clinical Trial
Immunotherapy Elicits Positive Response in Acute Myeloid Leukemia and Myelodysplastic Syndromes Patients
source: pixabay.com

Immunotherapy Elicits Positive Response in Acute Myeloid Leukemia and Myelodysplastic Syndromes Patients

According to a story from mdmag.com, a recent study that was presented at the 2019 meeting of the American Society of Clinical Oncology has demonstrated the potential of a two…

Continue Reading Immunotherapy Elicits Positive Response in Acute Myeloid Leukemia and Myelodysplastic Syndromes Patients

New Target Identified to Treat Acute Myeloid Leukemia and Mantle Cell Lymphoma

Mantle cell lymphoma (MCL) and acute myeloid leukemia (AML) are two rare forms of blood cancer with a high unmet need. The majority of cases in these patient populations are…

Continue Reading New Target Identified to Treat Acute Myeloid Leukemia and Mantle Cell Lymphoma

The LLS Ground-Breaking Precision Medicine Approach Master Trial  BEAT AML Releases Third Year Test Results

  A recent posting by the Leukemia and Lymphoma Society references the Beat AML Master Trial. The trial evaluates targeted therapies to treat acute myeloid leukemia (AML) and was launched…

Continue Reading The LLS Ground-Breaking Precision Medicine Approach Master Trial  BEAT AML Releases Third Year Test Results
Could This Investigational Drug be a New Treatment Option for Acute Myeloid Leukemia?
qimono / Pixabay

Could This Investigational Drug be a New Treatment Option for Acute Myeloid Leukemia?

According to a story from globenewswire.com, the biopharmaceutical company Innovation Pharmaceuticals recently released a report in which recent studies and pre-clinical research has suggested that the company's experimental drug Kevetrin…

Continue Reading Could This Investigational Drug be a New Treatment Option for Acute Myeloid Leukemia?

Study Indicates More Research is Needed on Transgender Acute Myeloid Leukemia Patients to Improve Patient Care

In a world that is just beginning to make space for the open discussion of transgender individual's life experiences, there's still a huge gap in the conversation regarding healthcare. This…

Continue Reading Study Indicates More Research is Needed on Transgender Acute Myeloid Leukemia Patients to Improve Patient Care

New Phase 1 Clinical Trial for Mastocytosis, MDS, and AML has Just Begun!

GT Biopharma has just announced that their Phase 1 clinical trial for Mastocytosis, Myelodysplastic Syndrome (MDS), and Acute Myeloid Leukemia (AML) has been authorized to begin. Although this investigation had previously…

Continue Reading New Phase 1 Clinical Trial for Mastocytosis, MDS, and AML has Just Begun!

Experimental Combination Treatment for Acute Myeloid Leukemia Shows Potential in Early Trial

According to a story from BioPortfolio, the biopharmaceutical company AVEO Pharmaceuticals and the lung cancer diagnostic company Biodesix recently released the results from the Phase Ib clinical trial testing a…

Continue Reading Experimental Combination Treatment for Acute Myeloid Leukemia Shows Potential in Early Trial
Close Menu